CliffBio
small molecule

ESTAZOLAM

ESTAZOLAM

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameESTAZOLAM
Active ingredientESTAZOLAM
Strength1MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1997
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.